CSTL
Price
$22.15
Change
+$0.87 (+4.09%)
Updated
Mar 28, 6:59 PM EST
38 days until earnings call
PROF
Price
$8.53
Change
+$0.41 (+5.05%)
Updated
Mar 28, 6:59 PM EST
38 days until earnings call
Ad is loading...

Compare predictions CSTL vs PROF

Header iconCSTL vs PROF Comparison
Open Charts CSTL vs PROFBanner chart's image
Castle Biosciences
Price$22.15
Change+$0.87 (+4.09%)
Volume$248.25K
CapitalizationN/A
Profound Medical
Price$8.53
Change+$0.41 (+5.05%)
Volume$7.74K
CapitalizationN/A
View a ticker or compare two or three
CSTL vs PROF Comparison Chart

Loading...

CSTLDaily Signal changed days agoGain/Loss if shorted
 
Show more...
PROFDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
CSTL vs. PROF commentary
Mar 29, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CSTL is a Buy and PROF is a Hold.

COMPARISON
Comparison
Mar 29, 2024
Stock price -- (CSTL: $22.15 vs. PROF: $8.53)
Brand notoriety: CSTL and PROF are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: CSTL: 148% vs. PROF: 37%
Market capitalization -- CSTL: $608.02M vs. PROF: $205.4M
CSTL [@Medical Specialties] is valued at $608.02M. PROF’s [@Medical Specialties] market capitalization is $205.4M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $7.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CSTL’s FA Score shows that 0 FA rating(s) are green whilePROF’s FA Score has 0 green FA rating(s).

  • CSTL’s FA Score: 0 green, 5 red.
  • PROF’s FA Score: 0 green, 5 red.
According to our system of comparison, PROF is a better buy in the long-term than CSTL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CSTL’s TA Score shows that 7 TA indicator(s) are bullish while PROF’s TA Score has 5 bullish TA indicator(s).

  • CSTL’s TA Score: 7 bullish, 3 bearish.
  • PROF’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, CSTL is a better buy in the short-term than PROF.

Price Growth

CSTL (@Medical Specialties) experienced а +4.98% price change this week, while PROF (@Medical Specialties) price change was +2.03% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.84%. For the same industry, the average monthly price growth was -0.26%, and the average quarterly price growth was +4.27%.

Reported Earning Dates

CSTL is expected to report earnings on May 06, 2024.

PROF is expected to report earnings on May 06, 2024.

Industries' Descriptions

@Medical Specialties (+0.84% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
A.I.dvisor published
a Summary for CSTL with price predictions.
OPEN
A.I.dvisor published
a Summary for PROF with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
CSTL($608M) has a higher market cap than PROF($205M). CSTL YTD gains are higher at: 2.641 vs. PROF (0.471). PROF has higher annual earnings (EBITDA): -26.78M vs. CSTL (-45.02M). CSTL has more cash in the bank: 243M vs. PROF (26.2M). PROF has less debt than CSTL: PROF (7.94M) vs CSTL (15.3M). CSTL has higher revenues than PROF: CSTL (220M) vs PROF (7.2M).
CSTLPROFCSTL / PROF
Capitalization608M205M297%
EBITDA-45.02M-26.78M168%
Gain YTD2.6410.471561%
P/E RatioN/AN/A-
Revenue220M7.2M3,056%
Total Cash243M26.2M927%
Total Debt15.3M7.94M193%
FUNDAMENTALS RATINGS
PROF: Fundamental Ratings
PROF
OUTLOOK RATING
1..100
62
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
PROFIT vs RISK RATING
1..100
85
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
60
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CSTLPROF
RSI
ODDS (%)
Bullish Trend 1 day ago
85%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
72%
Momentum
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 1 day ago
70%
MACD
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 1 day ago
77%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
78%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
82%
Bullish Trend 1 day ago
79%
Advances
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 1 day ago
78%
Declines
ODDS (%)
Bearish Trend 14 days ago
87%
Bearish Trend 4 days ago
79%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
89%
Bearish Trend 1 day ago
82%
Aroon
ODDS (%)
Bullish Trend 1 day ago
78%
N/A
View a ticker or compare two or three
Ad is loading...
CSTLDaily Signal changed days agoGain/Loss if shorted
 
Show more...
PROFDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LVOOX20.960.06
+0.29%
Lord Abbett Value Opportunities F3
RFIMX6.990.01
+0.14%
Ranger Micro Cap Institutional
OTPIX158.66N/A
N/A
ProFunds NASDAQ-100 Inv
STRSX28.35N/A
N/A
Sterling Capital Special Opps R6
OSMAX43.37-0.18
-0.41%
Invesco International Small-Mid Com A

CSTL and

Correlation & Price change

A.I.dvisor indicates that over the last year, CSTL has been loosely correlated with RVTY. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if CSTL jumps, then RVTY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CSTL
1D Price
Change %
CSTL100%
+4.09%
RVTY - CSTL
49%
Loosely correlated
-0.39%
CLPT - CSTL
35%
Loosely correlated
+1.34%
CDNA - CSTL
34%
Loosely correlated
+0.57%
IART - CSTL
30%
Poorly correlated
+1.78%
MYGN - CSTL
30%
Poorly correlated
-0.37%
More

PROF and

Correlation & Price change

A.I.dvisor tells us that PROF and BIO have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PROF and BIO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PROF
1D Price
Change %
PROF100%
+3.02%
BIO - PROF
24%
Poorly correlated
-1.06%
SEQL - PROF
24%
Poorly correlated
N/A
HSDT - PROF
23%
Poorly correlated
+4.11%
ANGO - PROF
23%
Poorly correlated
+3.07%
ZIMV - PROF
23%
Poorly correlated
+0.92%
More